This site is intended for healthcare professionals only
Temporary closures dominated the headlines this year. But laying the sole blame for them on a shortage of pharmacists or rising locum rates somewhat misses the point, says C+D’s editor Beth Kennedy
Well, what a year it’s been for community pharmacy. After two years where COVID-19 reigned supreme in the news cycle, any hopes pharmacy teams had that the pressure would let up in 2022 were dashed as workloads continued to rise and funding stayed stagnant.
Register to gain full access to C+D and C+D Community content
Already registered?
Already registered?
There will be a huge reliance on the senior team at Boots to deliver whatever plan transpires, and to prepare pharmacy teams for whatever difficult decisions will be coming. And they will be difficult.
‘Vote no’ campaigner Martin Astbury tells C+D why he believes the RPS plans for change represent a shift away from pharmacist leadership and why members should vote against them this week…
I also read comments that CPE does not appreciate this critical position, and I fundamentally refute that. Knowing the colleagues, both elected and employed, at CPE as I do, this is far from the case.
Community pharmacy is risk adverse, considered, and dare I say it, conservative. But, when it comes to the survival of pharmacy, we can’t afford to let the fear of change – or those resistant to it - hold us back.
How has the role of a pharmacy technician been professionalised, and what's their place within community pharmacy’s future?
